Lincoln, Nebraska – February 6, 2017 – TELCOR Inc is honored to be a sponsor of the 2017 Molecular Med Tri-Con conference. This annual conference focuses on molecular medicine, specifically on discovery, genomics, diagnostic and information technology.

Going on its 24th year, more than 3,500 professionals will attend this annual conference to discuss and debate changes in the industry while at the same time, acquire tangible solutions to overcoming barriers to coverage.

As an industry leader in helping laboratories become efficient and improve collections for services provided, TELCOR is excited to announce Kurt Matthes, RCM vice president, will speak Sunday, February 19 at 2:45 p.m. on coverage and reimbursement for advanced diagnostics.

“There are many challenges facing laboratories today,” said Matthes. “This discussion will cover best practices on how to operationalize preauthorization requirements, how to create a strategy for combatting narrow provider networks, and how to maximize collections in light of these issues.”

To discover how TELCOR RCM provides tools to overcome tough challenges and improve profitability, please contact Marketing Director Karis Ahlberg at 402-489-1207 or marketing@telcor.com.

 

###

TELCOR is the proven leader in the laboratory revenue cycle and point of care testing markets, providing unparalleled software products, services and exceptional customer support. Our proven implementations are performed by clinically experienced, IT knowledgeable resources who understand each customer’s unique environment.